This statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2024 to 2030. In 2028, the industry is expected to have 100 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.
In 2028, cancer drug Keytruda is expected to generate nearly 31 billion U.S. dollars in sales revenue worldwide, while Opdivo, also a cancer drug, is forecasted to generate around 15.7 billion U.S. dollars in sales revenue in the same year. This statistic illustrates a 2028 sales forecast for the most selling pharmaceutical drugs worldwide.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[240+ Pages Report] The global Pharmaceutical market size is expected to grow from USD 1,482.4 million to USD 2,067.36 million by 2028, at a CAGR of 5.70% from 2022-2028
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
Global size & share of AI for Pharmaceutical market is estimated to cross USD 8150 Million by 2026, growing at a CAGR of 47% between 2020 and 2026. AI has the potential to accelerate the new discovery and also increase productivity reducing the cost of operation and time to market.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
Global Pharmaceutical Intermediates market is expected to grow at a CAGR of 4% and is anticipated to reach around USD 36209 Million by 2026. Pharmaceutical intermediates are present in active pharmaceutical ingredients that are used in making drugs for the treatment of diseases.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[225+ Pages Report] The global active pharmaceutical ingredients market size was estimated at USD 191.3 billion in 2022 and is predicted to surpass over USD 306.2 billion by 2030 and is poised to reach a CAGR of 4.7% during the forecast period 2023 to 2030.
Revenue of the OTC pharmaceuticals market in Argentina was estimated at 385.5 million U.S. dollars in 2022. The market's segment accounting for the highest revenue share that year was skin treatment, with a value of approximately 121.4 million U.S. dollars. That year, digestive and intestinal remedies accounted for 90.05 million U.S. dollars of the total OTC pharmaceuticals market revenue in the South American country. In comparison, vitamins and minerals were estimated at 30.36 million U.S. dollars.
Find more key insights for the Pharmaceuticals market such as the value of pharmaceutical imports into Argentina.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[222+ Pages Report] The global Herbal Medicine market size is expected to grow from USD 166 billion in 2021 to USD 348 billion by 2028, at a CAGR of 11.2% from 2022-2028
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[218+ Pages Report] The global Cell-based Assays market size is expected to grow from USD 14,829.50 million to USD 23,143.57 million by 2028, at a CAGR of 7.70% from 2022-2028
https://bullfincher.io/privacy-policyhttps://bullfincher.io/privacy-policy
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
Global medical gases and equipment market is expected to grow at a CAGR of 6.2% and is anticipated to reach around USD 23,999.1 Million by 2026. Growing funding for healthcare research across the globe due to ongoing COVID-19 pandemic is major factor driving growth of the global medical gases and equipment’s market.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[197+ Pages Report] Global biohacking market growing with a CAGR growth of 21.1% and will reach USD 65.4 Billion in the year 2026.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[171+ Pages Report] Global Biotechnology Instruments Market Size & share is estimated to reach USD 80,051.1 Million by 2026, at a CAGR value of 12.66% during 2021-2026.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
Global Cleanroom Technologies market anticipated to reach around USD 8.10 Billion by 2026 and is expected to grow at a CAGR of 6.8% through 2026. The primary reasons expected to boost the global Cleanroom Technologies market is the strict government rules and regulations and also the development taking place in the biologics area.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[209+ Pages Report] The Global Nitrogen Market size is expected to reach USD 21.7 Billion by 2028, at a CAGR value of 5.8% during 2021-2028.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[192+ Pages Report] Global biomedical sensors market size & share estimated to reach USD 16.78 Billion by 2026, at a CAGR of 6.3% during the forecast period 2021-2026. The key players in the market are often seen integrating their consumers and their products by often updating their current line of product by functions of mergers & acquisitions.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[213+ pages Report] Global RFID in healthcare market size & share to surpass USD 3.5 Billion in the year 2026, at a CAGR value of 12.7% during the forecast period of 2021-2026
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
[225+ Pages Report] Global 3D Cell Culture Market size & share expected to reach USD 2.92 Billion by 2026, and will rise by 10.5% CAGR by 2020 to 2026. Three-dimensional cell culture is an in-vitro technique that allows cells to expand in an artificial environment.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
The global cell culture market is anticipated to reach around USD 37.41 Billion by 2026 and is expected to grow at a CAGR of 13% through 2026. Cell Culture is basically a process of developing cells under suitable conditions. The conditions vary as per the type of cell cultured.
https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy
Facts & Factors offers [209+ Pages Report] on global flavors and fragrance market size & share estimated to reach USD 35.3 Billion by 2026, with a expected CAGR of 5.9% during 2021-2026.
This statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2024 to 2030. In 2028, the industry is expected to have 100 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.